MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12985-024-02561-1

Медицинская библиотека · Virology journal · 2024

HBeAg-positive CHB patients with indeterminate phase associated with a high risk of significant fibrosis.

Li Yuanyuan, Zhu Yijia, Gao Dongmei, Pan Yifan, Wang Jian, Zhang Shaoqiu, Yan Xiaomin, Zhu Li, Zhu Chuanwu, Liu Xingxiang, Zhang Zhaoping, Li Jie, Chen Yuxin, Huang Rui, Wu Chao

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The risk of liver fibrosis in HBeAg-positive chronic hepatitis B (CHB) patients with indeterminate phase is not well characterized. We aimed to compare the presence of liver fibrosis in HBeAg-positive CHB patients between indeterminate phase and immune-tolerant phase.

METHODS

This multi-center, retrospective cohort study included 719 treatment-naïve HBeAg-positive CHB patients with normal alanine aminotransferase (ALT). Patients with HBV DNA > 106 IU/mL were categorized into immune-tolerant phase, whereas those with HBV DNA ≤ 106 IU/mL were classified into indeterminate phase. Significant liver fibrosis and cirrhosis were determined by APRI, FIB-4, transient elastography, or liver biopsy.

RESULTS

The median age of patients was 33.0 years and 59.8% of patients were male. 81.5% and 18.5% of patients were in the immune-tolerant phase and indeterminate phase, respectively. The APRI (0.33 vs. 0.27, P < 0.001), FIB-4 (1.07 vs. 0.72, P < 0.001), and liver stiffness values (7.80 kPa vs. 5.65 kPa, P = 0.011) were higher in patients with indeterminate phase than those with immune-tolerant phase. Patients in the indeterminate phase had significantly higher proportions of significant fibrosis (27.1% vs. 11.3%, P < 0.001) and cirrhosis (14.3% vs. 3.2%, P < 0.001) compared to those in the immune-tolerant phase. In the multivariate analysis, indeterminate phase (OR 2.138, 95% CI 1.253, 3.649, P = 0.005) was associated with a higher risk of significant fibrosis, especially for patients aged ≥ 30 years.

CONCLUSION

HBeAg-positive CHB patients in the indeterminate phase had more severe liver fibrosis compared to those in the immune-tolerant phase.

Для цитирования: Li Yuanyuan, Zhu Yijia, Gao Dongmei, Pan Yifan, Wang Jian, Zhang Shaoqiu, Yan Xiaomin, Zhu Li, Zhu Chuanwu, Liu Xingxiang, Zhang Zhaoping, Li Jie, Chen Yuxin, Huang Rui, Wu Chao. HBeAg-positive CHB patients with indeterminate phase associated with a high risk of significant fibrosis.. Virology journal. 2024. DOI: 10.1186/s12985-024-02561-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.